How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal inves- tigation of patients' self-management practices following atten- dance at a Dose Adjustment for Normal Eating (DAFNE) course. Diabet Med 2011; 28: 532-538....
Lawton, . (2011) How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients’ self-management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) cours. Diabetic Medicine 28 ,...
It can't be taken orally, as the digestive enzymes of the stomach degrade it. It will lose its function. Therefore, insulin is not administered orally. Similar questions Q. Question 4 Why are some patients with diabetes treated by giving injections of insulin? Q.Insulin is injected into the...
Understanding Ketoacidosis In diabetes, there is a lack of enough insulin in our body. Insulin is required to open the so-called glucose gates of our cells so that that glucose can enter the body's cells. Being insulin deficit, body tissues cannot optimally utilize glucose. There is high blo...
doi:10.1016/j.sapharm.2012.08.070S. Gnanasan and K.N. Ting and K.T. Wong and Mohd Ali S and A.R. Muttalif and C. AndersonResearch in Social and Administrative Pharmacy
As a DC, you can and should do a much better job than the medical establishment typically does at giving these patients effective relief that doesn’t cause bothersome side effects or actual harm. Here’s why. Dangers associated with NSAIDs ...
insulin directly through patients, or through pharmacies they themselves own, cutting out middlemen and the retail pharmacies. Thus, they lose the incentive to find the lowest price insulin for their patients. Insulin companies also focus on ‘insulin-starts’, or the insulin the physician ...
Why is it necessary for patients to keep a record of their response to drug therapy?Question:Why is it necessary for patients to keep a record of their response to drug therapy?Drug Therapy:The treatment and prevention of diseases through the application of drugs or medi...
The diabetes community welcomed an additional tool to their armamentarium with the US Food and Drug Administration (FDA)’s clearance of Sequel Med Tech’s twiist automated insulin delivery (AID) system in March 2024. Cleared for use in patients aged ≥6 years with type 1 diabetes (T1D), ...
The expression of the interleu- kin-1-receptor antagonist is reduced in pancreatic islets of patients with type 2 diabetes mellitus. High glucose induces the production of interleukin-1β in human pancreatic beta cells, leading to impaired insulin secretion, decreased cell pro- liferation, and ...